Researchers find that aspirin reduces the risk of cancer recurrence in prostate cancer patients
Monday, May 2, 2011 - 09:50
in Health & Medicine
Some studies have shown that blood-thinning medications, such as aspirin, can reduce biochemical failurecancer recurrence that is detected by a rising prostate-specific antigen (PSA) levelthe risk of metastasis and even death in localized prostate cancer. These studies, although very telling, have all emphasized the need for more data. Now, with researchers at Fox Chase Cancer Center having concluded the largest study on this topic, and there is substantial data suggesting that aspirin improves outcomes in prostate cancer patients who have received radiotherapy.